ARTCLINE Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
17
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$9.8M
- Investors
-
1
ARTCLINE General Information
Description
Operator of an immune cell-based extracorporeal therapy intended for treating sepsis. The company provides allogeneic immune cell therapy, removal of inflammatory substances, and production of immunological messengers, enabling healthcare providers to treat sepsis, reduce mortality rates, and improve patient outcomes in intensive care units.
Contact Information
Website
www.artcline.deCorporate Office
- Schillingallee 68
- 18057 Rostock
- Germany
Corporate Office
- Schillingallee 68
- 18057 Rostock
- Germany
ARTCLINE Timeline
ARTCLINE Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Later Stage VC | 09-Sep-2026 | $9.8M | Completed | Clinical Trials - General | ||
| 1. Later Stage VC | 25-Mar-2024 | Completed | Clinical Trials - General |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
ARTCLINE Patents
ARTCLINE Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4154925-A1 | Immune cell treatment | Inactive | 22-Sep-2021 | ||
| EP-4404991-A1 | Immune cell treatment | Pending | 22-Sep-2021 | ||
| US-20250144279-A1 | Immune cell treatment | Pending | 22-Sep-2021 | ||
| WO-2023046874-A1 | Immune cell treatment | Inactive | 22-Sep-2021 | ||
| DE-102012209673-A1 | A method for producing a leukocyte preparation and leukocyte preparation | Inactive | 08-Jun-2012 | A61K35/16 |
ARTCLINE Signals
ARTCLINE Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern | Venture Capital | Minority |
ARTCLINE FAQs
-
When was ARTCLINE founded?
ARTCLINE was founded in 2007.
-
Where is ARTCLINE headquartered?
ARTCLINE is headquartered in Rostock, Germany.
-
What is the size of ARTCLINE?
ARTCLINE has 17 total employees.
-
What industry is ARTCLINE in?
ARTCLINE’s primary industry is Biotechnology.
-
Is ARTCLINE a private or public company?
ARTCLINE is a Private company.
-
What is ARTCLINE’s current revenue?
The current revenue for ARTCLINE is .
-
How much funding has ARTCLINE raised over time?
ARTCLINE has raised $14.5M.
-
Who are ARTCLINE’s investors?
Mittelständische Beteiligungsgesellschaft Mecklenburg-Vorpommern has invested in ARTCLINE.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process